PTC-028
PTC-028 is an orally bioavailable inhibitor of stem cell factor BMI-1 in ovarian cancer. PTC-028 selectively inhibits cancer cells whereas normal cells remain unaffected. PTC-028 downregulates BMI-1, inducing caspase-mediated apoptosis[1].
Product Specifications
CAS Number
1782970-28-8
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Apoptosis; BMI1
Type
Reference compound
Related Pathways
Apoptosis; Stem Cell/Wnt
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/ptc-028.html
Purity
98.0
Solubility
DMSO : 125 mg/mL (ultrasonic)
Smiles
FC(C1=CC=C(NC2=NC(N3C4=CC(F)=C(F)C=C4N=C3C)=CN=C2)C=C1)(F)F
Molecular Formula
C19H12F5N5
Molecular Weight
405.32
Precautions
H302, H315, H319, H335
References & Citations
[1]Dey A, et al. Evaluating the Mechanism and Therapeutic Potential of PTC-028, a Novel Inhibitor of BMI-1 Function in Ovarian Cancer. Mol Cancer Ther. 2018 Jan;17 (1) :39-49.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6280512-01 0.1 mL
CALCR, CT (CALCR, Calcitonin receptor) (MaxLight 405)
Sign In for Pricing
View Details MBS6280512-02 5x 0.1 mL
CALCR, CT (CALCR, Calcitonin receptor) (MaxLight 405)
Sign In for Pricing
View Details